Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosa Fonti

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Cancers|January 23, 2024
Coefficient of Variation in Metastatic Lymph Nodes Determined by <sup>18</sup>F-FDG PET/CT in Patients with Advanced NSCLC: Combination with Coefficient of Variation in Primary TumorsSara Pellegrino, Rosa Fonti, Carlo Vallone, et al.
Biomedicines|June 26, 2025
Texture Analysis of 68Ga-DOTATOC PET/CT Images for the Prediction of Outcome in Patients with Neuroendocrine TumorsSara Pellegrino, Mariarosaria Panico, Roberto Bologna, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|March 8, 2017
Evaluation of metabolic response with <sup>18</sup>F-FDG PET-CT in patients with advanced or recurrent thymic epithelial tumorsSabrina Segreto, Rosa Fonti, Margaret Ottaviano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2015
Reversal of Warburg Effect and Reactivation of Oxidative Phosphorylation by Differential Inhibition of EGFR Signaling Pathways in Non-Small Cell Lung CancerViviana De Rosa, Francesca Iommelli, Marcello Monti, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 10, 2004
Functional imaging of multidrug resistant phenotype by 99mTc-MIBI scan in patients with multiple myelomaRosa Fonti, Silvana Del Vecchio, Antonella Zannetti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 25, 2002
Dynamic coupling of 99mTc-MIBI efflux and apoptotic pathway activation in untreated breast cancer patientsSilvana Del Vecchio, Antonella Zannetti, Andrea Ciarmiello, et al.
Annals of Hematology|July 24, 2024
Coefficient of variation and texture analysis of 18F-FDG PET/CT images for the prediction of outcome in patients with multiple myelomaSara Pellegrino, Davide Origlia, Erica Di Donna, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 17, 2012
Metabolic tumor volume assessed by 18F-FDG PET/CT for the prediction of outcome in patients with multiple myelomaRosa Fonti, Michele Larobina, Silvana Del Vecchio, et al.
Clinical Nuclear Medicine|December 30, 2014
Prognostic role of 18F-FDG PET/CT in the postoperative evaluation of differentiated thyroid cancer patientsLeonardo Pace, Michele Klain, Barbara Salvatore, et al.
Clinical Nuclear Medicine|January 22, 2015
18F-FDG PET/CT, 99mTc-MIBI, and MRI in the prediction of outcome of patients with multiple myeloma: a comparative studyRosa Fonti, Leonardo Pace, Claudio Cerchione, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Cancers|January 23, 2024
Coefficient of Variation in Metastatic Lymph Nodes Determined by <sup>18</sup>F-FDG PET/CT in Patients with Advanced NSCLC: Combination with Coefficient of Variation in Primary TumorsSara Pellegrino, Rosa Fonti, Carlo Vallone, et al.
Biomedicines|June 26, 2025
Texture Analysis of 68Ga-DOTATOC PET/CT Images for the Prediction of Outcome in Patients with Neuroendocrine TumorsSara Pellegrino, Mariarosaria Panico, Roberto Bologna, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|March 8, 2017
Evaluation of metabolic response with <sup>18</sup>F-FDG PET-CT in patients with advanced or recurrent thymic epithelial tumorsSabrina Segreto, Rosa Fonti, Margaret Ottaviano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2015
Reversal of Warburg Effect and Reactivation of Oxidative Phosphorylation by Differential Inhibition of EGFR Signaling Pathways in Non-Small Cell Lung CancerViviana De Rosa, Francesca Iommelli, Marcello Monti, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 10, 2004
Functional imaging of multidrug resistant phenotype by 99mTc-MIBI scan in patients with multiple myelomaRosa Fonti, Silvana Del Vecchio, Antonella Zannetti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 25, 2002
Dynamic coupling of 99mTc-MIBI efflux and apoptotic pathway activation in untreated breast cancer patientsSilvana Del Vecchio, Antonella Zannetti, Andrea Ciarmiello, et al.
Annals of Hematology|July 24, 2024
Coefficient of variation and texture analysis of 18F-FDG PET/CT images for the prediction of outcome in patients with multiple myelomaSara Pellegrino, Davide Origlia, Erica Di Donna, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 17, 2012
Metabolic tumor volume assessed by 18F-FDG PET/CT for the prediction of outcome in patients with multiple myelomaRosa Fonti, Michele Larobina, Silvana Del Vecchio, et al.
Clinical Nuclear Medicine|December 30, 2014
Prognostic role of 18F-FDG PET/CT in the postoperative evaluation of differentiated thyroid cancer patientsLeonardo Pace, Michele Klain, Barbara Salvatore, et al.
Clinical Nuclear Medicine|January 22, 2015
18F-FDG PET/CT, 99mTc-MIBI, and MRI in the prediction of outcome of patients with multiple myeloma: a comparative studyRosa Fonti, Leonardo Pace, Claudio Cerchione, et al.
Pageof 6